• Journal of Korean Society for Atmospheric Environment
• /
• v.16 no.4
• /
• pp.421-428
• /
• 2000

Accelerator Mass Spectrometry (AMS) is presented for the applications to the environmental research. Traditionally the radiocarbon (14C) measurements have been made for the purpose of dating the archaeological and geological samples. 14C measurements using AMS however have become the more useful methods for the study of environmental science such as antropogenic modification of atmosphere and the determination of mixing ratios of fossil and biomass products. Such 14C AMS measurements have been extended to the discovery of new chemical tracers for investigations of sources of excessive contributions of CO2, CO, CH4 and other carbon-bearing molecules in the atmosphere.

• YAKHAK HOEJI
• /
• v.57 no.6
• /
• pp.412-419
• /
• 2013

Drug discovery and development processes are time consuming and costly endeavors. It has been reported that on average it takes 10 to 15 years and costs more than $ 1billion to bring a molecule from discovery to market. Compounds fail for various reasons but one of the significant reasons that accounts for failures in clinical trials is poor prediction/understanding of pharmacokinetics and drug metabolism in human. In an effort to improve the number of compounds that exhibit optimal absorption, distribution, metabolism, elimination (ADME), and pharmacokinetic properties in human, drug metabolism, pharmacokinetic scientists have been continually developing new technologies and compound screening strategies. Over the last few years, accelerator mass spectrometry (AMS) and its applications to preclinical/clinical pharmacokinetics and ADME studies have significantly increased, particularly for new chemical/biological entities that are difficult to support with conventional radiolabel studies. In this review, the application of AMS for micro-dosing, micro-tracer absolute bioavailability, mass balance and metabolite profiling studies will be discussed.

• Journal of Radiopharmaceuticals and Molecular Probes
• /
• v.6 no.1
• /
• pp.20-26
• /
• 2020

Accelerator mass spectrometry (AMS) is a powerful detection technique with the exquisite sensitivity and high precision compared with other traditional analytical techniques. Accelerator mass spectrometry can be widely applied in the technique of radiocarbon dating in the fields of archeology, geology and oceanography. The ability of accelerator mass spectrometry to measure rare ¹⁴C concentrations in microgram and even sub-microgram amounts suggests that extension of ¹⁴C-accelerator mass spectrometry to biomedical field is a natural and attractive application of the technology. Drug development processes are costly, risky, and time consuming. However, the use of ¹⁴C-accelerator mass spectrometry allows absorption, distribution, metabolism and excretion (ADME) studies easier to understand pharmacokinetics of drug candidates. Over the last few decades, accelerator mass spectrometry and its applications to preclinical/clinical trials have significantly increased. For accelerator mass spectrometry analysis of biological samples, graphitization processes of samples are important. In this paper, we present a detailed sample preparation procedure to apply to graphitization of biological samples for accelerator mass spectrometry.

• Nuclear Engineering and Technology
• /
• v.55 no.8
• /
• pp.3114-3120
• /
• 2023

A high-accuracy magnetic field measurement device based on a cyclotron is being developed for accelerator mass spectrometry (AMS). In this study, a magnetic field measurement device consisting of a Hall probe sensor, piezo-motor, and step motor was developed to measure the magnetic field of the AMS cyclotron magnet. The Hall probe sensor was calibrated to achieve positional accuracy by using polar coordinates. The measurement results between the ratchet gear and piezo-motor, which are the instruments used for driving the measurement device, were analyzed. The measurement result of the device with a piezo-motor exhibits a difference of 5 Gauss (0.04%) as compared with the simulation result.

• Proceedings of the Korean Vacuum Society Conference
• /
• 2013.02a
• /
• pp.243-244
• /
• 2013

Over the past 15 years, several groups have incorporated radio-frequency quadrupole (RFQ) based instruments before the accelerator in accelerator mass spectrometry (AMS) systems for ion-gas interactions at low kinetic energy (＜40 eV). Most AMS systems arebased on a tandem accelerator, which requires negative ions at injection. Typically, AMS sensitivity abundance ratios for radioactive-to-stable isotope are limited to Xr/Xs ＞10^-15, and the range of isotopes that can be analyzed is limited because of theneed to produce rather large negative ion beams and the presence of atomic isobaric interferences after stripping. The potential of using low-kinetic energy ion-gas interactions for isobar suppression before the accelerator has been demonstrated for several negative ion isobar systems with a prototype RFQ system incorporated into the AMS system at IsoTrace Laboratory, Canada (Ontario, Toronto). Requisite for any such RFQ system applied to very rare isotope analysis is large transmission of the analyte ion. This requires proper phase-space matching between the RFQ acceptance and the ion beam phase space (e.g. 35 keV, ${\varphi}3mm$, +-35 mrad), and the ability to control the average ion energy during interactions with the gas. A segmented RFQ instrument is currently being designed at Korea Institute for Science and Technology (한국과학기술연구원, KIST). It will consist of: a) an initial static voltage electrode deceleration region, to lower the ion energy from 35 keV down to ＜40 eV at injection into the first RFQ segment; b) the segmented quadrupole ion-gas interaction region; c) a static voltage electrode re-acceleration region for ion injection into a tandem accelerator. Design considerations and modeling will be discussed. This system should greatly lower the detection limits of the 6 MV AMS system currently being commissioned at KIST. As an example, current detection sensitivity of 41Ca/Ca is limited to the order of 10^-15 while the 41Ca/Ca abundance in modern samples is typically 41Ca/Ca~10^-14 - 10^-15. The major atomic isobaric interference in AMS is 41K. Proof-of-principal work at IsoTrace Lab. has demonstrated that a properly designed system can achieve a relative suppression of KF3-/41CaF3- ＞4 orders of magnitude while maintaining very high transmission of the 41CaF3- ion. This would lower the 41Ca detection limits of the KIST AMS system to at least 41Ca/Ca~10^-19. As Ca is found in bones and shells, this would potentially allow direct dating of valuable anthropological archives and archives relevant to our understanding of the most pronounced climate change events over the past million years that cannot be directly dated with the presently accessible isotopes.

• Proceedings of the Korea Air Pollution Research Association Conference
• /
• 1999.10a
• /
• pp.103-107
• /
• 1999

가속기 질량분광분석법(Accelerator Mass Spectrometry; AMS)은 동위원소 분석에 있어 초정밀 질량 분석 기술에 속한다. 시료(Samples)의 원자를 이온화 시켜 가속시키고, 에너지, 운동량 그리고 전하 상태를 분석하여 최종 얻고자 하는 원자핵의 동위원소, 예를 들어 탄소-14$^{14)C$),의 수를 정확하게 측정하는 분광분석 기술이다. 본 논문을 통하여 AMS를 소개하고 대기 환경 연구에 AMS가 어떻게 응용될 수 있는지 살펴 보기로 한다.(중략)

• Journal of Radiation Industry
• /
• v.17 no.2
• /
• pp.127-134
• /
• 2023

Pharmacokinetic (PK) data provide pivotal information in drug development, and they are usually first studied in the preclinical stage using various animals. However, quite often, animal PK data may not match with human PK, especially in metabolites. Thus, most regulatory agencies in the world make it mandatory to obtain metabolite information using ¹⁴C radiolabeled drug in human for small molecule drug candidates. However, such studies are expensive and time consuming and they are usually done at the end of Phase II trials using ~3.7 MBq of ¹⁴C labeled drug in a limited number of human subjects. Introduction of accelerator mass spectrometry (AMS) in this kind of study has revolutionized it. Since AMS can measure ¹⁴C level as close as natural abundance, it can quantify the amounts of ¹⁴C labeled drugs and their metabolites produced in human body that consumes less than the amount of 0.0037 MBq of ¹⁴C labeled drug, a very safe level of radioactive dose in human. Therefore, it is now possible to conduct human ¹⁴C studies safely in early clinical trials without spending hefty amount of money and time. Korea Radioisotope Center for Pharmaceuticals(KRICP) at Korea Institute of Biological and Medical Sciences(KIRAMS) has established an AMS facility in 2018, housing a 0.5MV AMS manufactured at the US National Electrostatics Corps (NEC). The AMS instrument has been validated using various standard samples that have been prepared at Lawrence Livermore National Laboratory in the US, a worldly reputable provider of AMS standards. In this paper, we present a mass balance study for acetaminophen in rats using AMS and prove that the study results are equivalent with those of literature, which shows the AMS facilities at KRICP has successfully installed and be ready to be used in the various PK studies using ¹⁴C labelled compounds for new drug development.

• Journal of the Korean Wood Science and Technology
• /
• v.45 no.5
• /
• pp.572-579
• /
• 2017

Determination of the wood content in wood plastic composite (WPC) is crucial to form reliable WPC market. WPC with simple formulation consisting of only two components (wood flour and polypropylene) was examined using thermogravimetric analysis (TGA) and accelerator mass spectrometry (AMS) for determining wood content in the WPC. TGA method using derivative peak temperature (DTp) of polypropylene under low heating rate ($5^{\circ}C/min$) showed more reliable calibration curve and lower error factor compared to method of using the percentage of weight loss of wood flour. In addition, AMS using bio-based carbon content showed greater reliability for the determination of wood content in the WPC in comparison with the TGA method.

• The Korean Journal of Quaternary Research
• /
• v.4 no.1
• /
• pp.27-40
• /
• 1990

$^{14}C$ age dating by AMS (accelerator mass spectrometry) technique was performed on twenty five small sized fossil shells and one peat taken from the sixteen piston cores in the southern and southeastern Korean Sea. AMS technique is available to date only a few milligram of amorphous carbons compare than conventional dating technique. It is described in detail of sample pre-treatment and experimental, and applied to the reconstruction of the sea level changes since the late Pleistocene in the Korean Sea. Dated age ranges from 520$\pm$100 to older than 33,500 years. Sedimentary facies in the study area represents a different environmental set which is affected by sea level fluctuation since the late Pleistocene.

• Nuclear Engineering and Technology
• /
• v.54 no.12
• /
• pp.4636-4643
• /
• 2022

A time-of-flight and energy (TOF-E) detection system for the measurement of ²³⁶U accelerator mass spectrometry (AMS) has been developed to improve the ²³⁶U/²³⁸U sensitivity at Micro Analysis Laboratory, Tandem accelerator (MALT), The University of Tokyo. With observing TOF distribution of ²³⁵U, ²³⁶U and ²³⁸U, this TOF-E detection system has clearly separated ²³⁶U from the interference of ²³⁵U and ²³⁸U when measuring three kinds of uranium standards. In addition, we have developed a novel method combining kernel-based density estimation method and multi-Gaussian fitting method to estimate the ²³⁶U/²³⁸U sensitivity of the TOF-E detection system. Using this new estimation method, 3.4 × 10^-12 of ²³⁶U/²³⁸U sensitivity and 1.9 ns of time resolution are obtained. ²³⁶U/²³⁸U sensitivity of TOF-E detection system has improved two orders of magnitude better than that of previous gas ionization chamber. Moreover, unknown species other than uranium isotopes were also observed in the measurement of a surface soil sample, which has demonstrated that TOF-E detection system has a higher sensitivity in particle identification. With its high sensibility in mass determination, this TOF-E detection system could also be used in other heavy isotope AMS.